Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Cogan syndrome is a rare autoimmune disorder primarily characterized by ocular inflammation and vestibulo-auditory dysfunction. While it is officially recognized as Cogan syndrome, it is occasionally referred to in historical or specialized literature as Cogan’s oculovestibuloauditory syndrome or nonsyphilitic interstitial keratitis with vestibuloauditory symptoms. What are the historical and alternative names for Cogan syndrome? The medical nomenclature for Cogan syndrome has evolved since it was first described in 1945 by Dr.
1 people with Cogan syndrome have shared their first-person experience on this question at DiseaseMaps.
TL;DR: Cogan syndrome is a rare autoimmune disorder primarily characterized by ocular inflammation and vestibulo-auditory dysfunction. While it is officially recognized as Cogan syndrome, it is occasionally referred to in historical or specialized literature as Cogan’s oculovestibuloauditory syndrome or nonsyphilitic interstitial keratitis with vestibuloauditory symptoms.
The medical nomenclature for Cogan syndrome has evolved since it was first described in 1945 by Dr. David G. Cogan. In earlier medical literature, the condition was frequently described by its clinical presentation rather than an eponym, leading to terms such as "nonsyphilitic interstitial keratitis with vestibuloauditory symptoms." This descriptive name was essential historically to distinguish the condition from syphilitic interstitial keratitis, which was a common differential diagnosis at the time. You may also encounter the term "Cogan’s oculovestibuloauditory syndrome," which combines the three primary systems involved: the eyes (ocular), the balance organs (vestibular), and the hearing apparatus (auditory).
In modern clinical practice and standardized medical coding, Cogan syndrome is the universally accepted term. It is indexed in major databases to ensure consistency across international medical records. For example, in the Orphanet database, it is classified under the unique identifier ORPHA:197, and it is documented in OMIM (Online Mendelian Inheritance in Man) as entry #206250. Because Cogan syndrome is an autoimmune condition rather than a single genetic mutation, its classification focuses on its systemic nature, often grouping it among the systemic vasculitides due to the inflammation of blood vessels that can occur in some patients.
The existence of multiple names for Cogan syndrome is primarily due to the transition from descriptive clinical terminology to eponyms. Medical professionals prefer the name Cogan syndrome today because it is concise and facilitates clear communication across international borders and specialties, including rheumatology, ophthalmology, and otolaryngology. Using the official eponym prevents confusion with other inflammatory eye conditions that might share similar symptoms but have entirely different underlying causes or treatment protocols.
When searching for information or reviewing medical records, it is helpful to be aware of the following terms associated with Cogan syndrome:
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional regarding any clinical concerns.